Luteolin attenuates cognitive dysfunction induced by chronic cerebral hypoperfusion through the modulation of the PI3K/Akt pathway in rats

1Araujo J.A., Chan A.D., Winka L.L., Seymour P.A., Milgram N.W.: Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination. Psychopharmacology 2004, 175, 92–98, doi: 10.1007/s00213-004-1777-y. Araujo J.A. Chan A.D. Winka L.L. Seymour P.A. Milgram N.W. Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination Psychopharmacology 2004 175 92 98 10.1007/s00213-004-1777-yOpen DOISearch in Google Scholar

2Araujo J.A., Landsberg G.M., Milgram N.W., Miolo A.: Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine. Can Vet J 2008, 49, 379–385. Araujo J.A. Landsberg G.M. Milgram N.W. Miolo A. Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine Can Vet J 2008 49 379 385Search in Google Scholar

3Araujo J.A., Studzinski C.M., Head E., Cotman C.W., Milgram N.W.: Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging. Age (Dordrecht, Netherlands) 2005, 27, 27–37, doi: 10.1007/s11357-005-4001-z. Araujo J.A. Studzinski C.M. Head E. Cotman C.W. Milgram N.W. Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging Age (Dordrecht, Netherlands) 2005 27 27 37 10.1007/s11357-005-4001-zOpen DOISearch in Google Scholar

4Arcaro A., Guerreiro A.S.: The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. Curr Genomics 2007, 8, 271–306, doi: 10.2174/138920207782446160. Arcaro A. Guerreiro A.S. The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications Curr Genomics 2007 8 271 306 10.2174/138920207782446160Open DOISearch in Google Scholar

5Bowen M., Edgar D.F., Hancock B., Haque S., Shah R., Buchanan S., Iliffe S., Maskell S., Pickett J., Taylor J.-P., O’Leary N.: The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross-sectional study of people aged 60–89 years with dementia and qualitative exploration of individual, carer and professional perspectives. Health Serv Deliv Res 2016, 4, doi: 10.3310/hsdr04210. Bowen M. Edgar D.F. Hancock B. Haque S. Shah R. Buchanan S. Iliffe S. Maskell S. Pickett J. Taylor J.-P. O’Leary N. The Prevalence of Visual Impairment in People with Dementia (the PrOVIDe study): a cross-sectional study of people aged 60–89 years with dementia and qualitative exploration of individual, carer and professional perspectives Health Serv Deliv Res 2016 4 10.3310/hsdr04210Open DOISearch in Google Scholar

6Chen G., Shen H., Zang L., Su Z., Huang J., Sun Y., Wang H.: Protective effect of luteolin on skin ischemia-reperfusion injury through an AKT-dependent mechanism. Int J Mol Med 2018, 42, 3073–3082, doi: 10.3892/ijmm.2018.3915. Chen G. Shen H. Zang L. Su Z. Huang J. Sun Y. Wang H. Protective effect of luteolin on skin ischemia-reperfusion injury through an AKT-dependent mechanism Int J Mol Med 2018 42 3073 3082 10.3892/ijmm.2018.3915Open DOISearch in Google Scholar

7Cummings B.J., Head E., Afagh A.J., Milgram N.W., Cotman C.W.: Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol Learn Mem 1996, 66, 11–23, doi: 10.1006/nlme.1996.0039. Cummings B.J. Head E. Afagh A.J. Milgram N.W. Cotman C.W. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine Neurobiol Learn Mem 1996 66 11 23 10.1006/nlme.1996.0039Open DOISearch in Google Scholar

8Cummings B.J., Satou T., Head E., Milgram N.W., Cole G.M., Savage M.J., Podlisny M.B., Selkoe D.J., Siman R., Greenberg B.D., Cotman C.W.: Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs. Neurobiol Aging 1996, 17, 653–659, doi: 10.1016/0197-4580(96)00062-0. Cummings B.J. Satou T. Head E. Milgram N.W. Cole G.M. Savage M.J. Podlisny M.B. Selkoe D.J. Siman R. Greenberg B.D. Cotman C.W. Diffuse plaques contain C-terminal A beta 42 and not A beta 40: evidence from cats and dogs Neurobiol Aging 1996 17 653 659 10.1016/0197-4580(96)00062-0Open DOISearch in Google Scholar

9Dibble C.C., Cantley L.C.: Regulation of mTORC1 by PI3K signaling. Trends Cell Biol 2015, 25, 545–555, doi: 10.1016/j.tcb. 2015.06.002. Dibble C.C. Cantley L.C. Regulation of mTORC1 by PI3K signaling Trends Cell Biol 2015 25 545 555 10.1016/j.tcb.2015.06.002473463526159692Open DOISearch in Google Scholar

10Dodd C.E., Zicker S.C., Jewell D.E., Fritsch D.A., Lowry S.R., Allen T.A.: Can a fortified food affect the behavioral manifestations of age-related cognitive decline in dogs? Vet Med 2003, 98, 396–408. Dodd C.E. Zicker S.C. Jewell D.E. Fritsch D.A. Lowry S.R. Allen T.A. Can a fortified food affect the behavioral manifestations of age-related cognitive decline in dogs? Vet Med 2003 98 396 408Search in Google Scholar

11Duzgun Z., Eroglu Z., Biray Avci C.: Role of mTOR in glioblastoma. Gene 2016, 575, 187–190, doi: 10.1016/j.gene.2015.08.060. Duzgun Z. Eroglu Z. Biray Avci C. Role of mTOR in glioblastoma Gene 2016 575 187 190 10.1016/j.gene.2015.08.06026341051Open DOISearch in Google Scholar

12Edwards L.A., Thiessen B., Dragowska W.H., Daynard T., Bally M.B., Dedhar S.: Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene 2005, 24, 3596–3600, doi: 10.1038/sj.onc.1208427. Edwards L.A. Thiessen B. Dragowska W.H. Daynard T. Bally M.B. Dedhar S. Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth Oncogene 2005 24 3596 3600 10.1038/sj.onc.120842715782140Open DOISearch in Google Scholar

13Elmazoglu Z., Yar Saglam A.S., Sonmez C., Karasu C.: Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson’s disease and inflammatory pathways. Drug Chem Toxicol 2020, 43, 96–103, doi: 10.1080/01480545.2018.1504961. Elmazoglu Z. Yar Saglam A.S. Sonmez C. Karasu C. Luteolin protects microglia against rotenone-induced toxicity in a hormetic manner through targeting oxidative stress response, genes associated with Parkinson’s disease and inflammatory pathways Drug Chem Toxicol 2020 43 96 103 10.1080/01480545.2018.1504961Open DOISearch in Google Scholar

14Farkas E., Luiten P.G., Bari F.: Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 2007, 54, 162–180, doi: 10.1016/j.brainresrev.2007.01.003. Farkas E. Luiten P.G. Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases Brain Res Rev 2007 54 162 180 10.1016/j.brainresrev.2007.01.003Open DOISearch in Google Scholar

15Feng F.B., Qiu H.Y.: Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritis. Biomed Pharmacother 2018, 102, 1209– 1220, doi: 10.1016/j.biopha.2018.03.142. Feng F.B. Qiu H.Y. Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritis. Biomed Pharmacother 2018 102 1209–1220 10.1016/j.biopha.2018.03.142Open DOISearch in Google Scholar

16Fu X., Zhang J., Guo L., Xu Y., Sun L., Wang S., Feng Y., Gou L., Zhang L., Liu Y.: Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats. Pharmacol Biochem Behav 2014, 126, 122–130, doi: 10.1016/ j.pbb.2014.09.005. Fu X. Zhang J. Guo L. Xu Y. Sun L. Wang S. Feng Y. Gou L. Zhang L. Liu Y. Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats Pharmacol Biochem Behav 2014 126 122 130 10.1016/j.pbb.2014.09.005Open DOISearch in Google Scholar

17Head E., McCleary R., Hahn F.F., Milgram N.W., Cotman C.W.: Region-specific age at onset of beta-amyloid in dogs. Neurobiol Aging 2000, 21, 89–96, doi: 10.1016/s0197-4580(00)00093-2. Head E. McCleary R. Hahn F.F. Milgram N.W. Cotman C.W. Region-specific age at onset of beta-amyloid in dogs Neurobiol Aging 2000 21 89 96 10.1016/s0197-4580(00)00093-2Open DOISearch in Google Scholar

18Heath S.E., Barabas S., Craze P.G.: Nutritional supplementation in cases of canine cognitive dysfunction - A clinical trial. App Anim Behav Sci 105, 284–296, doi: 10.1016/j.applanim. 2006.11.008. Heath S.E. Barabas S. Craze P.G. Nutritional supplementation in cases of canine cognitive dysfunction - A clinical trial App Anim Behav Sci 105 284 296 10.1016/j.applanim.2006.11.008Open DOISearch in Google Scholar

19Heras-Sandoval D., Pérez-Rojas J.M., Hernández-Damián J., Pedraza-Chaverri J.: The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 2014, 26, 2694– 2701, doi: 10.1016/j.cellsig.2014.08.019. Heras-Sandoval D. Pérez-Rojas J.M. Hernández-Damián J. Pedraza-Chaverri J. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration Cell Signal 2014 26 2694–2701 10.1016/j.cellsig.2014.08.019Open DOISearch in Google Scholar

20Jain V., Baitharu I., Prasad D., Ilavazhagan G.: Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF/PI3K/GSK3β pathway coupled with CREB activation. PLoS One 2013, 8, e62235, doi: 10.1371/journal.pone.0062235. Jain V. Baitharu I. Prasad D. Ilavazhagan G. Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF/PI3K/GSK3β pathway coupled with CREB activation PLoS One 2013 8 e62235 10.1371/journal.pone.0062235Open DOISearch in Google Scholar

21Kataoka-Kato A., Ukai M., Sakai M., Kudo S., Kameyama T.: Enhanced learning of normal adult rodents by repeated oral administration of soybean transphosphatidylated phosphatidylserine. J Pharmacol Sci 2005, 98, 307–314, doi: 10.1254/jphs.fp0050366. Kataoka-Kato A. Ukai M. Sakai M. Kudo S. Kameyama T. Enhanced learning of normal adult rodents by repeated oral administration of soybean transphosphatidylated phosphatidylserine J Pharmacol Sci 2005 98 307 314 10.1254/jphs.fp0050366Open DOISearch in Google Scholar

22Kavirajan H., Schneider L.S.: Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol 2007, 6, 782–792, doi: 10.1016/s1474-4422(07)70195-3. Kavirajan H. Schneider L.S. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials Lancet Neurol 2007 6 782 792 10.1016/s1474-4422(07)70195-3Open DOISearch in Google Scholar

23Landsberg G.M., Nichol J., Araujo J.A.: Cognitive dysfunction syndrome: a disease of canine and feline brain aging. Vet Clin North Am Small Anim Pract 2012, 42, 749–768, doi: 10.1016/j.cvsm.2012.04.003. Landsberg G.M. Nichol J. Araujo J.A. Cognitive dysfunction syndrome: a disease of canine and feline brain aging Vet Clin North Am Small Anim Pract 2012 42 749 768 10.1016/j.cvsm.2012.04.00322720812Open DOISearch in Google Scholar

24Lee R.H.C., Lee M.H.H., Wu C.Y.C., Do Couto e Silva A., Possoit H.E., Hsieh T.H., Minagar A., Lin H.W.: Cerebral ischemia and neuroregeneration. Neural Regen Res 2018, 13, 373–385, doi: 10.4103/1673-5374.228711. Lee R.H.C. Lee M.H.H. Wu C.Y.C. Do Couto e Silva A. Possoit H.E. Hsieh T.H. Minagar A. Lin H.W. Cerebral ischemia and neuroregeneration Neural Regen Res 2018 13 373 385 10.4103/1673-5374.228711590049029623912Open DOISearch in Google Scholar

25Liu P., Cheng H., Roberts T.M., Zhao J.J.: Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov 2009, 8, 627–644, doi: 10.1038/nrd2926. Liu P. Cheng H. Roberts T.M. Zhao J.J. Targeting the phosphoinositide 3-kinase pathway in cancer Nat Rev Drug Discov 2009 8 627 644 10.1038/nrd2926314256419644473Open DOISearch in Google Scholar

26Sánchez-Alegría K., Flores-León M., Avila-Muñoz E., Rodríguez-Corona N., Arias C.: PI3K Signaling in Neurons: A Central Node for the Control of Multiple Functions. Int J Mol Sci 2018, 19, doi: 10.3390/ijms19123725. Sánchez-Alegría K. Flores-León M. Avila-Muñoz E. Rodríguez-Corona N. Arias C. PI3K Signaling in Neurons: A Central Node for the Control of Multiple Functions Int J Mol Sci 2018 19 10.3390/ijms19123725632129430477115Open DOISearch in Google Scholar

27Sun G.B., Sun X., Wang M., Ye J.X., Si J.Y., Xu H.B., Meng X.B., Qin M., Sun J., Wang H.W., Sun X.B.: Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression. Toxicol Appl Pharmacol 2012, 265, 229–240, doi: 10.1016/j.taap.2012.10.002. Sun G.B. Sun X. Wang M. Ye J.X. Si J.Y. Xu H.B. Meng X.B. Qin M. Sun J. Wang H.W. Sun X.B. Oxidative stress suppression by luteolin-induced heme oxygenase-1 expression Toxicol Appl Pharmacol 2012 265 229 240 10.1016/j.taap.2012.10.00223051850Open DOISearch in Google Scholar

28Xu F., Na L., Li Y., Chen L.: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours. Cell Biosci 2020,10, 54, doi: 10.1186/s13578-020-00416-0. Xu F. Na L. Li Y. Chen L. Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours Cell Biosci 202010 54 10.1186/s13578-020-00416-0711090632266056Open DOISearch in Google Scholar

29Zhang S., Qi Y., Xu Y., Han X., Peng J., Liu K., Sun C.K.: Protective effect of flavonoid-rich extract from Rosa laevigata Michx on cerebral ischemia-reperfusion injury through suppression of apoptosis and inflammation. Neurochem Int 2013, 63, 522–532, doi: 10.1016/j.neuint.2013.08.008. Zhang S. Qi Y. Xu Y. Han X. Peng J. Liu K. Sun C.K. Protective effect of flavonoid-rich extract from Rosa laevigata Michx on cerebral ischemia-reperfusion injury through suppression of apoptosis and inflammation Neurochem Int 2013 63 522 532 10.1016/j.neuint.2013.08.00824012531Open DOISearch in Google Scholar

30Zhang X., Du Q., Yang Y., Wang J., Dou S., Liu C., Duan J.: The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway. Biomed Pharmacother 2017, 91, 1042–1052, doi: 10.1016/j.biopha.2017.05.033. Zhang X. Du Q. Yang Y. Wang J. Dou S. Liu C. Duan J. The protective effect of Luteolin on myocardial ischemia/reperfusion (I/R) injury through TLR4/NF-κB/NLRP3 inflammasome pathway Biomed Pharmacother 2017 91 1042 1052 10.1016/j.biopha.2017.05.03328525945Open DOISearch in Google Scholar